Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 241274
IPSCIO Record ID: 282938
Licensor shall supply to Licensee, and Licensee shall purchase from Licensor all of Licensees requirements for the CombiPatch Product for sale in the Territory subject to the terms and conditions set forth herein. Licensor shall also exclusively supply Licensee, and Licensee shall purchase from Licensor all of Licensees requirements for Licensed Products other than the CombiPatch Product for sale in the Territory.
CombiPatch Product, at Licensees option, shall be supplied in finished, packaged and labeled form or in bulk rolls.
The term Licensed Product shall have the meaning set forth in the Licensor License Agreement, as amended. The term Licensed Product or shall mean individually and collectively any Estrogen Transdermal Drug Delivery System or any Combination Estrogen/Progestin Drug Delivery System. A Licensed Product relating to the Estrogen Transdermal Drug Delivery System shall be referred to as an 'Estrogen Product' and a Licensed Product relating to the Combination Estrogen/Progestin Drug Delivery System shall be referred to as a 'Combination Product.'
The term Licensors Technology' shall have the meaning set forth in the Licensor License Agreement in so far as it relates to any combination estrogen/progestin in a polymer adapted for transdermal delivery by application to the epidermis, other than combinations indicated for contraceptive use.
CombiPatch(TM) is a transdermal combination estrogen/progestin delivery system.
CombiPatch (estradiol, norethindrone acetate transdermal system) is a combination of female hormones used to treat the symptoms of menopause such as feelings of warmth in the face, neck and chest, or sudden intense spells of heat and sweating ('hot flashes' or 'hot flushes'); to treat vulvar and vaginal changes.
IPSCIO Record ID: 211862
Licensor has developed, and owns the right to use, certain data and information pertaining to the synthetic steroid Nestorone(R) (17-acetoxy-16-methylene-19-norprogesterone).
Licensor and the manufacturer of Nestorone(R) have entered into an agreement for, among, other things, the supply of Nestorone(R), to manufacturers of products incorporating Nestorone(R), including products for use in the field of human reproductive health.
Nestorone and Elcometrine, is a progestin of the 19-norprogesterone group which is used as a hormonal contraceptive and in the treatment of endometriosis.
Endometriosis is a condition in which the layer of tissue that normally covers the inside of the uterus grows outside of it. Most often this is on the ovaries, fallopian tubes, and tissue around the uterus and ovaries; however, in rare cases it may also occur in other parts of the body.
The tradename registered is Nestorone(R).